Donor and isolation variables predicting human islet isolation success

Transplantation

Volumn 85, Issue 7, 2008, Pages 950-955

  Hanley, Stephen C ^a,b   Paraskevas, Steven ^a,b   Rosenberg, Lawrence ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Cell volume; Human; Islet; Isolation; Success; Variables

Indexed keywords

ADULT; AGE; ARTICLE; CADAVER DONOR; CELL COUNT; CELL ISOLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PREDICTION; PRIORITY JOURNAL; PROTEINASE INHIBITION;

ADULT; BODY MASS INDEX; CADAVER; CELL SEPARATION; FEMALE; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PATIENT SELECTION; REGRESSION ANALYSIS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS;

EID: 42149118941     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181683df5     Document Type: Article

References (39)

1. Kloppel G, Lohr M, Habich K, et al. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 1985; 4: 110.
2. Atkinson MA, Eisenbarth GS. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 221.
3. Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102.
4. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003; 46: 3.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977.
6. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study. JAMA 2003; 290: 2159.
7. Sutherland DE, Gruessner RW, Gruessner AC. Pancreas transplantation for treatment of diabetes mellitus. World J Surg 2001; 25: 487.
8. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
9. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
10. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
11. Gershengorn MC, Hardikar AA, Wei C, et al. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 2004; 306: 2261.
12. Jamal AM, Lipsett M, Sladek R, et al. Morphogenetic plasticity of adult human pancreatic islets of Langerhans. Cell Death Differ 2005; 12: 702.
13. Gao R, Ustinov J, Korsgren O, et al. In vitro neogenesis of human islets reflects the plasticity of differentiated human pancreatic cells. Diabetologia 2005; 48: 2296.
14. Lechner A, Nolan AL, Blacken RA, et al. Redifferentiation of insulin-secreting cells after in vitro expansion of adult human pancreatic islet tissue. Biochem Biophys Res Commun 2005; 327: 581.
15. Ouziel-Yahalom L, Zalzman M, Anker-Kitai L, et al. Expansion and redifferentiation of adult human pancreatic islet cells. Biochem Biophys Res Commun 2006; 341: 291.
16. Zeng Y, Torre MA, Karrison T, et al. The correlation between donor characteristics and the success of human islet isolation. Transplantation 1994; 57: 954.
17. Matsumoto I, Sawada T, Nakano M, et al. Improvement in islet yield from obese donors for human islet transplants. Transplantation 2004; 78: 880.
18. Nano R, Clissi B, Melzi R, et al. Islet isolation for allotransplantation: Variables associated with successful islet yield and graft function. Diabetologia 2005; 48: 906.
19. Ricordi C, Lacy PE, Finke EH, et al. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413.
20. Lipsett MA, Austin EB, Castellarin ML, et al. Evidence for the homeostatic regulation of induced beta cell mass expansion. Diabetologia 2006; 49: 2910.
21. Benhamou PY, Watt PC, Mullen Y, et al. Human islet isolation in 104 consecutive cases. Factors affecting isolation success. Transplantation 1994; 57: 1804.
22. Brandhorst H, Brandhorst D, Hering BJ, et al. Body mass index of pancreatic donors: A decisive factor for human islet isolation. Exp Clin Endocrinol Diabetes 1995; 103(suppl 2): 23.
23. Lakey JR, Warnock GL, Rajotte RV, et al. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 1996; 61: 1047.
24. Mahler R, Franke FE, Hering BJ, et al. Evidence for a significant correlation of donor pancreas morphology and the yield of isolated purified human islets. J Mol Med 1999; 77: 87.
25. Oberholzer J, Triponez F, Mage R, et al. Human islet transplantation: Lessons from 13 autologous and 13 allogeneic transplantations. Transplantation 2000; 69: 1115.
26. Goto M, Eich TM, Felldin M, et al. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 2004; 78: 1367.
27. Rose NL, Palcic MM, Shapiro AM, et al. Endogenous pancreatic enzyme activity levels show no significant effect on human islet isolation yield. Cell Transplant 2004; 13: 153.
28. Kim SC, Han DJ, Kang CH, et al. Analysis on donor and isolation-related factors of successful isolation of human islet of Langerhans from human cadaveric donors. Transplant Proc 2005; 37: 3402.
29. Sabek OM, Cowan P, Fraga DW, et al. The effect of donor factors on human islet yield and their in vivo function. Prog Transplant 2006; 16: 350.
30. Salehi P, Mirbolooki M, Kin T, et al. Ameliorating injury during preservation and isolation of human islets using the two-layer method with perfluorocarbon and UW solution. Cell Transplant 2006; 15: 187.
31. Lakey JR, Helms LM, Kin T, et al. Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia. Transplantation 2001; 72: 565.
32. Lakey JR, Warnock GL, Shapiro AM, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 1999; 8: 285.
33. Meier JJ, Butler AE, Monchamp T, et al. Beta-cell replication is the primary mechanism for postnatal expansion of beta-cell mass in humans. Diabetes 2007; 56(suppl 1): A47.
34. Close N, Alejandro R, Hering B, et al. Second annual analysis of the collaborative islet transplant registry. Transplant Proc 2007; 39: 179.
35. Kin T, Murdoch TB, Shapiro AM, et al. Estimation of pancreas weight from donor variables. Cell Transplant 2006; 15: 181.
36. Matsumoto S, Zhang G, Qualley S, et al. Analysis of donor factors affecting human islet isolation with current isolation protocol. Transplant Proc 2004; 36: 1034.
37. Aikin R, Hanley S, Maysinger D, et al. Autocrine insulin action activates Akt and increases survival of isolated human islets. Diabetologia 2006; 49: 2900.
38. Hanley S, Liu S, Lipsett M, et al. Tumor necrosis factor-alpha production by human islets leads to postisolation cell death. Transplantation 2006; 82: 813.
39. Saisho Y, Butler AE, Monchamp T, et al. Does beta-cell mass adaptively increase in response to obesity in humans? Diabetes 2007; 56(suppl 1): A48.